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Background
Soluble guanylyl cyclase (sGC) constitutes a family of
enzymes that catalyses the cyclization of guanosine 5’-tri-
phosphate (GTP) to guanosine 3’,5’-cyclic monophosphate
(cGMP). The heterodimeric hemoprotein is activated by
nitric oxide and mediates a wide range of physiological
effects like regulation of blood pressure and neuronal cell
development. sGC is an important target for the treatment
of cardiovascular diseases.
In addition to the biosynthesis of cGMP, we recently
showed that invitro and in presence of Mn
2+ ions sGC
also generates the cyclic purine nucleotides adenosine
3’,5’-cyclic monophosphate (cAMP), inosine 3’,5’-cyclic
monophosphate (cIMP), and xanthosine 3’,5’-cyclic
monophosphate (cXMP)[1]. For all purine nucleotides, a
second low-affinity site was described[1]. Moreover,
sGC shows a pyrimidinylyl cyclase activity for uridine
3’,5’-cyclic monophosphate (cUMP) and cytosine 3’,5’-
cyclic monophosphate (cCMP). In this case, no second
binding site could be identified[1]. Lastly, no formation
of the cyclic desoxyribonucleotide thymidine 3’,5’-cyclic
monophosphate (cTMP) was detected[1].
Materials and methods
For in vitro assays and determination of Michaelis-Men-
ten kinetic parameters highly purified recombinant sGC
from rat (a1b1) was activated by sodium nitroprusside
(100 µM). sGC (0.1-20 ng/tube) was incubated at 37°C
with 3 mM MnCl2 or MgCl2 and various concentrations
of nucleoside 5’-triphosphates (NTPs). Samples were
stopped by heating at 95°C. Concentrations of cyclic
nucleotides were determined by HPLC-MS/MS.
The in vivo assays were performed using transiently
a1b1-transfected HEK 293 and endogenously sGC-
expressing rat fetal lung fibroblast RFL-6 cells[2]. Cells
were stimulated with SNP (100 µM) with or without
phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine
(IBMX, 100 µM). After defined times medium was
removed and cell metabolism was stopped by addition
of organic solvent and by heating at 98°C. After centri-
fugation clear supernatant was taken for quantitation of
cyclic nucleotides by HPLC-MS/MS.
Results
Analyzing in vitro substrate specificity in presence of Mg
2
+ revealed that cyclase activity of sGC is limited to purine
nucleotides. Beside cGMP, cAMP, cIMP, and cXMP, but
no cUMP and cCMP were generated. Additionally, in
contrast to Mn
2+ as cofactor, kinetics could be described
c o m p l e t e l yu s i n gam o d e lo fas i n g l eb i n d i n gs i t e ,s u g -
gesting that when Mg
2+ ions are present only one high-
affinity binding site is active.
However, studying transiently sGC-transfected
HEK293 and endogenously sGC-expressing RFL-6 cells
after SNP-stimulation we could detect a time-dependent
accumulation of cGMP and cAMP as well as a generation
of cCMP and cUMP. cXMP, cIMP and cTMP could not
been detected. The addition of IBMX could only inhibit
degradation of cGMP and cAMP while concentrations of
cCMP and cUMP were only marginally influenced. These
data indicate that Mn
2+ rather than Mg
2+ is the relevant
divalent cation for sGC. Moreover, cCMP and cUMP
appear to be hydrolysis-resistant in HEK293 and RFL-6
cells. Figure 1.
Conclusion
1 .I nt h ep r e s e n c eo fM g
2+, sGC exhibits one catalytic
center but in the presence of Mn
2+, there are two cata-
lytic centers.
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3 .T h e s ed a t ai n d i c a t et h a tin vivo,M n
2+ rather than
Mg
2+ may be the relevant divalent cation for sGC.
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Figure 1 Model of two catalytic active binding sites in sGC
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